Publications by authors named "Wesley Burks"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

407

Total Likes

338

Extended Reach

5,531,925

Social Features

147
P
Peanut Component-Specific IgE and IgG4 Are Modulated by Sublingual Immunotherapy and Are Associated With Remission in 1-4-Year-Old Children.
Neel Singh, Janelle Kesselring, Jess Humphrey, Lauren Herlihy, A Wesley Burks

Allergy· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of epicutaneous immunotherapy in children with peanut allergy with atopic comorbidities.
Amy M Scurlock, David M Fleischer, George Du Toit, Nicolette J T Arends, Jacqueline A Pongracic, A Wesley Burks

Ann Allergy Asthma Immunol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline basophil activation and early suppression is associated with clinical outcome after peanut sublingual immunotherapy.
Jessica R Humphrey, Rishu Guo, Xiaohong Yue, Corinne A Keet, Yamini V Virkud, A Wesley Burks

J Allergy Clin Immunol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of bile acids, amino acids, and glycerophospholipid metabolites with food-allergic outcomes in children on peanut oral immunotherapy.
Jennifer N Styles, Justin K Wang, Ananya Raman, Michael Lu, Jessica A Lasky-Su, Wesley A Burks

medRxiv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-Allergic Toddlers: Open-Label Extension to EPITOPE.
Matthew Greenhawt, Deborah Albright, Sara Anvari, Nicolette Arends, Peter D Arkwright, A Wesley Burks

J Allergy Clin Immunol Pract· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
To Eat or Not to Eat - Oral Immunotherapy for High-Threshold Peanut Allergy.
Corinne A Keet, A Wesley Burks

NEJM Evid· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epicutaneous immunotherapy for the treatment of peanut allergy.
Mayuran Ravindran, Hugh A Sampson, Edwin H Kim, Katharine J Bee, Todd D Green, A Wesley Burks

Allergy· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A mutation in Themis contributes to anaphylaxis severity following oral peanut challenge in CC027 mice.
Ellen L Risemberg, Johanna M Smeekens, Marta C Cruz Cisneros, Brea K Hampton, Pablo Hock, A Wesley Burks

J Allergy Clin Immunol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WALKING BACKWARDS: REFLECTING ON THE VALUE OF MENTORS.
Wesley Burks

Trans Am Clin Climatol Assoc· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of epicutaneous immunotherapy with DBV712 (peanut patch) in peanut allergy.
Christophe Dupont, A Wesley Burks, David M Fleischer, Katharine J Bee, Sarita Chainani

Expert Rev Clin Immunol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Desensitization and remission after peanut sublingual immunotherapy in 1- to 4-year-old peanut-allergic children: A randomized, placebo-controlled trial.
Edwin H Kim, J Andrew Bird, Corinne A Keet, Yamini V Virkud, Lauren Herlihy, A Wesley Burks

J Allergy Clin Immunol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal dynamics of the gut microbiome and metabolome in peanut allergy development.
Yoojin Chun, Alexander Grishin, Rebecca Rose, William Zhao, Zoe Arditi, A Wesley Burks

J Allergy Clin Immunol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A mutation in contributes to peanut-induced oral anaphylaxis in CC027 mice.
Ellen L Risemberg, Johanna M Smeekens, Marta C Cruz Cisneros, Brea K Hampton, Pablo Hock, A Wesley Burks

bioRxiv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Open-label study of the efficacy, safety, and durability of peanut sublingual immunotherapy in peanut-allergic children.
Edwin H Kim, Corinne A Keet, Yamini V Virkud, Stacy Chin, Ping Ye, A Wesley Burks

J Allergy Clin Immunol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allergen recognition by specific effector Th2 cells enables IL-2-dependent activation of regulatory T-cell responses in humans.
Daniel Lozano-Ojalvo, Scott R Tyler, Carlos J Aranda, Julie Wang, Scott Sicherer, A Wesley Burks

Allergy· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting CD22 on memory B cells to induce tolerance to peanut allergens.
LaKeya C Hardy, Johanna M Smeekens, Dharmendra Raghuwanshi, Susmita Sarkar, Gour C Daskhan, A Wesley Burks

J Allergy Clin Immunol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peanut-Specific IgG4 and IgA in Saliva Are Modulated by Peanut Oral Immunotherapy.
Johanna M Smeekens, Carolyn Baloh, Noha Lim, David Larson, Tielin Qin, A Wesley Burks

J Allergy Clin Immunol Pract· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinetics of basophil hyporesponsiveness during short-course peanut oral immunotherapy.
Michael D Kulis, Johanna M Smeekens, Caitlin Burk, Xiaohong Yue, Rishu Guo, A Wesley Burks

J Allergy Clin Immunol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Food-specific immunoglobulin A does not correlate with natural tolerance to peanut or egg allergens.
Elise G Liu, Biyan Zhang, Victoria Martin, John Anthonypillai, Magdalena Kraft, A Wesley Burks

Sci Transl Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel peanut-specific human IgE monoclonal antibodies enable screens for inhibitors of the effector phase in food allergy.
Jada Suber, Yugen Zhang, Ping Ye, Rishu Guo, A Wesley Burks

Front Immunol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply.
James Baker, Kirsten Beyer, George du Toit, Wayne Shreffler, Kari R Brown, Wesley Burks

J Allergy Clin Immunol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of peanut (Arachis hypogaea) allergen powder-dnfp in children and teenagers with peanut allergy: Pooled summary of phase 3 and extension trials.
Kari R Brown, James Baker, Andrea Vereda, Kirsten Beyer, A Wesley Burks

J Allergy Clin Immunol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping Sequential IgE-Binding Epitopes on Major and Minor Egg Allergens.
Maria Suprun, Scott H Sicherer, Robert A Wood, Stacie M Jones, Donald Y M Leung, A Wesley Burks

Int Arch Allergy Immunol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study.
Stacie M Jones, Edwin H Kim, Kari C Nadeau, Anna Nowak-Wegrzyn, Robert A Wood, A Wesley Burks

Lancet· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis